Skip to main content

SOP

Bleeding Time

A historical primary haemostasis screening procedure that measures the time required for bleeding to stop after a standardized skin injury.

Last verified 1 month ago 1 min read Coagulation Haematology #Bleeding Time #Primary Haemostasis
Link copied!
Document Control
Version
1.0
Effective
Aug 31, 2026
Reviewed
Aug 28, 2026
Department
Haematology
Principle

The procedure historically assessed the duration of bleeding after a standardized superficial skin injury.

Purpose

To describe the bleeding-time procedure and its important modern limitations.

Principle

A standardized superficial skin injury is historically produced and the duration of bleeding is measured under controlled conditions.

Current Practice Consideration

Bleeding time is now limited, restricted or discontinued in many modern laboratories because of poor standardization, limited predictive value and the availability of alternative platelet and haemostasis investigations.

Procedure

Where the test remains approved for use by an institution, it must be performed strictly according to the institution's current validated and ethically approved procedure by trained personnel.

The local procedure should address:

  • Patient selection and contraindications
  • Standardized technique
  • Timing method
  • Safety and bleeding management
  • Documentation and reporting
  • Escalation of prolonged bleeding

Quality and Safety

Patient safety, institutional approval, standardized technique and appropriate management of bleeding must be ensured.

Reporting

Results should be interpreted cautiously and according to current laboratory and clinical policy.

Safety

Because this procedure involves intentional skin injury, it requires strict institutional governance and appropriate patient safety measures.

Frequently Asked Questions

Its use is limited or discontinued in many modern settings because of methodological limitations and the availability of alternative investigations.
No. It should only be used where it remains institutionally approved, validated and clinically governed.